Compare LASR & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LASR | BHC |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2018 | N/A |
| Metric | LASR | BHC |
|---|---|---|
| Price | $54.84 | $6.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $37.86 | $8.67 |
| AVG Volume (30 Days) | 1.3M | ★ 2.2M |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $227,526,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $31.94 | $6.81 |
| Revenue Next Year | $11.78 | $4.11 |
| P/E Ratio | ★ N/A | $6.37 |
| Revenue Growth | ★ 12.05 | 5.86 |
| 52 Week Low | $6.20 | $4.25 |
| 52 Week High | $55.31 | $8.69 |
| Indicator | LASR | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 43.63 |
| Support Level | $41.51 | $5.62 |
| Resistance Level | $55.31 | $6.31 |
| Average True Range (ATR) | 3.73 | 0.20 |
| MACD | 0.65 | 0.04 |
| Stochastic Oscillator | 98.12 | 68.42 |
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.